Benzinga | Oct 28, 2020 05:39AM EDT

Baird Downgrades Varian Medical Systems to Neutral, Announces $178 Price Target

Baird analyst Jeff Johnson downgrades Varian Medical Systems (NYSE:VAR) from Outperform to Neutral and announces $178 price target.